WS-27 Cooling Agent: Shaanxi Baisfu Biotechnology Leads Industry Upgrades through Molecular Innovation

Introduction: When Technology Meets Coolness, a Revolution in Taste and Sensation Unfolds

In iced beverages on sweltering summer days and in the frothy lather of morning toothpaste, a cooling agent named WS-27, with its unique molecular structure, is redefining the experience of "coolness." As one of the core R&D achievements of Shaanxi Baisfu Biotechnology Co., Ltd. (hereinafter referred to as "Baisfu Biotechnology"), the WS-27 cooling agent has become a revolutionary raw material in industries such as food and beverage, daily chemicals, and tobacco, thanks to its technical advantages of high temperature resistance, low dosage requirements, and long-lasting effects. According to industry data, the market demand for WS-series cooling agents is growing at an average annual rate of over 40%. Through continuous technological breakthroughs, Baisfu Biotechnology is propelling this "cooling technology" to the forefront of the global market.

I. Technological Breakthrough: From Menthol to WS-27, a Precise Innovation in Molecular Structure

Traditional menthol can provide a cooling sensation, but its drawbacks, such as easy volatility, ineffectiveness at high temperatures, and strong irritation, have long plagued the industry. The R&D team of Baisfu Biotechnology successfully developed WS-27 (CAS 51115-70-9) through molecular structure modification technology. This white crystalline powder can maintain its cooling activity even at 200°C. It only requires a dosage of 30 - 100mg/kg to achieve the same effect as traditional menthol. Moreover, it leaves no bitter aftertaste and improves compatibility with other flavors by more than 30%.

"The introduction of a special amide group in the molecular structure of WS-27 makes its effect on the oral cavity and skin surface more gentle and long-lasting," pointed out the technical director of Baisfu Biotechnology. "By simulating the binding sites of human sensory receptors, we have achieved a balance between the 'burst' and 'duration' of the cooling sensation. Experimental data shows that the cooling duration of WS-27 is 2.3 times that of menthol, while the irritation index is reduced by 40%." This technological breakthrough not only solves the problem of cooling agent failure in baked goods but also achieves a "zero-irritation" sensory experience in oral care products.

II. Application Scenarios: From Food and Daily Chemicals to Industrial Innovation, the Diverse Value Release of WS-27

In the food industry, WS-27 has become the "cooling star" in candies, carbonated beverages, and dairy products. After a well-known beverage brand adopted the WS-27 formula, the retention rate of the cooling sensation of its products during high-temperature transportation increased by 50%, and the consumer repurchase rate rose by 22%. In the daily chemical industry, WS-27 is widely used in toothpaste, shower gels, and skin care products. Its "odorless and low-volatility" properties enable it to perfectly synergize with plant essential oils in shampoos. An international pet shampoo brand even gained a market reputation for "gentle coolness" due to the addition of WS-27.

It is worth noting that the application potential of WS-27 in the tobacco industry is being unleashed. Since it does not affect the original flavor of tobacco but can enhance the smoking experience through cooling adjustment, it has currently been included in the formulation systems of new tobacco products by many leading enterprises. With international certifications such as ISO9001, ISO14001, and Kosher, Baisfu Biotechnology ensures the safety and stability of WS-27 in various application scenarios. The product has been exported to more than 30 countries and regions around the world, and the company has established cooperative relationships with international giants such as Symrise and Givaudan.

III. Corporate Strength: Full-chain Innovation Capability under Policy Support

As a biotechnology enterprise rooted in Shaanxi, the R&D path of WS-27 by Baisfu Biotechnology has always been in line with national strategies. The 2025 Government Work Report clearly lists biological manufacturing as a future industry, and the molecular design and large-scale production of WS-27 are typical applications of biological manufacturing technology in the fine chemical industry. The company's R&D center in Xi'an has more than 10 years of technical accumulation in cooling agents. Its full-chain transformation capability, from laboratory pilot tests to 10,000-ton-level production, ensures the efficient progress of WS-27 from molecular design to market implementation.

"We are not just manufacturers of cooling agents; we are providers of sensory experience solutions," said the general manager of Baisfu Biotechnology. "With GPM-certified production lines, we achieve precise control of WS-27 purity above 99%. Continuous R&D investment (with an annual R&D expense ratio of over 5%) keeps us leading in the iteration of WS-series products." This technical confidence is the core advantage that enables the company to stand out in the highly competitive flavor and fragrance industry.

IV. Market Outlook: An 8,000-ton Blue Ocean of Demand, WS-27 Ushering in the Cooling Agent 2.0 Era

According to industry reports, the market size of WS-series cooling agents is expected to reach 8,000 tons in the next five years. Due to its comprehensive performance advantages, WS-27 is expected to account for more than 35% of this market. Under the trend of consumption upgrading, consumers' demands for "healthy, long-lasting, and gentle" sensory experiences are driving the technological iteration of cooling agents. Baisfu Biotechnology has already made early arrangements. Its newly developed high-yield process for WS-27 is accelerating industrialization through patent navigation projects, further reducing production costs and increasing market penetration.

From Xi'an to the world, Baisfu Biotechnology, with WS-27 as its pivot, is reshaping the technological landscape of the cooling agent industry. Just as the 2025 No. 1 Central Document emphasizes biological breeding, the essence of biological manufacturing lies in the innovation loop from molecules to industries. The story of WS-27 is not only the success of a single product but also an epitome of how Chinese biotechnology enterprises respond to national strategies and participate in global competition through technological breakthroughs.